Financial Enhancement Group’s Zimmer Biomet ZBH Stock Holding History

Financial Enhancement Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-95	Closed	-$10K	–	344
2022 Q2	$10K	Hold	95	–	–	﹤0.01%	191
2022 Q1	$12K	Sell	95 -3	-3%	-$362	﹤0.01%	185
2021 Q4	$12K	Hold	98	–	–	﹤0.01%	192
2021 Q3	$14K	Hold	98	–	–	﹤0.01%	185
2021 Q2	$15K	Hold	98	–	–	﹤0.01%	171
2021 Q1	$15K	Hold	98	–	–	﹤0.01%	163
2020 Q4	$15K	Hold	98	–	–	﹤0.01%	190
2020 Q3	$13K	Hold	98	–	–	﹤0.01%	165
2020 Q2	$11K	Sell	98 -101	-51%	-$11.6K	﹤0.01%	178
2020 Q1	$20K	Sell	199 -2	-1%	-$262	0.01%	167
2019 Q4	$29K	Hold	201	–	–	0.01%	149
2019 Q3	$27K	Sell	201 -24	-11%	-$3.1K	0.01%	156
2019 Q2	$26K	Hold	225	–	–	0.01%	154
2019 Q1	$28K	Hold	225	–	–	0.01%	157
2018 Q4	$29K	Hold	225	–	–	0.01%	145
2018 Q3	$29K	Hold	225	–	–	0.01%	145
2018 Q2	$24K	Sell	225 -15	-6%	-$1.63K	0.01%	145
2018 Q1	$25K	Buy	+240	New	+$27.9K	0.01%	144

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Financial Enhancement Group's ZBH Position: Q3 2022 in Review

Financial Enhancement Group sold out of Zimmer Biomet (ZBH) in Q3 2022, closing a stake of 95 shares — an estimated $10K sold.

Financial Enhancement Group first reported a position in ZBH in Q1 2018 and held it in 18 quarters. The position peaked at $29K in Q4 2019. 919 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.

Financial Enhancement Group reported no remaining Zimmer Biomet position as of Q3 2022 after selling out during the quarter.
Financial Enhancement Group sold 95 Zimmer Biomet shares in Q3 2022, an estimated $10K.
Financial Enhancement Group first reported a position in Zimmer Biomet in Q1 2018 and held it in 18 quarters.
Financial Enhancement Group's Zimmer Biomet position peaked at $29K in Q4 2019.
919 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.

Based on Financial Enhancement Group's 13F filing for Q3 2022, filed 27 Oct 2022.